Cutaneous T-cell lymphoproliferative disorders: Approach for the surgical pathologist: Recent advances and clarification of confused issues

Advances in Anatomic Pathology

Volumn 9, Issue 2, 2002, Pages 79-100

  Liu, Vincent ^a   McKee, Phillip H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CTCL; Cutaneous T cell lymphoma; Variants

Indexed keywords

CLASSIFICATION; CUTANEOUS T CELL LYMPHOMA; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS FUNGOIDES; PATHOLOGY; PRECANCER; PSEUDOLYMPHOMA; REVIEW; SKIN DISEASE; SKIN TUMOR;

GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, CUTANEOUS; LYMPHOPROLIFERATIVE DISORDERS; MYCOSIS FUNGOIDES; PRECANCEROUS CONDITIONS; PSEUDOLYMPHOMA; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0036512738     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200203000-00001     Document Type: Review

References (184)

1. Ming M, LeBoit PE. Can dermatopathologists reliably make the diagnosis of mycosis fungoides? Arch Dermatol 2000;4:543-6.
2. Smoller BR, Bishop K, Glusac E, et al. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995;19:1423-30.
3. Ferenczi K, McKee PH, Kupper TS. Cutaneous lymphoma. In: Sober AJ and Haluska FG, eds. Skin cancer. American Cancer Society Atlas of Clinical Oncology series. Hamilton, Ontario: BC Decker, 2001:85-117.
4. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sézary syndrome (CTCL): a review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994;18:645-667.
5. Glusac EJ, Shapiro PE, McNiff JM. CTCL. Refinement in the application of controversial histologic criteria. Dermatol Clin 1999;17:601-14.
6. Herbmann JJ, Kuzel TM, Rosen ST, et al. Proceedings of the Second International Symposium on T-cell lymphoproliferative disorders. J Am Acad Dermatol 1994;31:819-822.
7. Stansfield AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-3.
8. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
9. Willemze R, Beljarrds RC, Meijer CJLM. Classification of primary CTCL. Histopathology 1994;24:405-415.
10. Willemze R, Kerl H, Sterry W, et al. EORTC classifications for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
11. Lisby G, Reties MR, Vejlsgaard GL. No detection of HTLV1 DNA in punch biopsies from patients with cutaneous T cell lymphoma by the polymerase chain reaction. J Invest Dermatol 1992; 98:417-20.
12. Rijlaarsdam U, Willemze R. Cutaneous pseudo-T-cell lymphomas. Semin Diagn Pathol 1991;8:102-8.
13. Smolle J, Torne R, Soyer HP, et al. Immunohistochemical classification of cutaneous pseudolymphomas: delineation of distinct patterns. J Cutan Pathol 1990;17:149-159.
14. Duvic M, Moore P, Menter A, et al. CTCL in association with silicone breast implants. J Am Acad Dermatol 1995;32:939-42.
15. Kardaun SH, Scheffer E, Vermeer BJ. Drug-induced pseudolymphomatous skin reactions. Br J Dermatol 1988;118:545-52.
16. Rijlaarsdam U, Scheffer E, Meijer CJLM, et al. Mycosis fungoides- like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991;24:216-220.
17. Schreiber MM, McGregor JG. Pseudolymphoma syndrome. A sensitivity to anticonvulsant drugs. Arch Dermatol 1968;97:297-300.
18. D'Incan M, Souteyrand P, Bignon YJ, et al. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome. Arch Dermatol 1992;128: 1371-4.
19. Harris DWS, Ostlere L, Buckley C, et al. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol 1992;127:403-6.
20. Henderson CA, Shamy HK. Atenolol-induced pseudolymphoma. Clin Exp Dermatol 1990;15:119-20.
21. Magro CM, Crowson AN. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. J Am Acad Dermatol 1995;32:419-28.
22. Gupta AK, Cooper KD, Ellis CN, et al. Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol 1990;23:1137-41.
23. van der Putte SCJ, Toonstra J, Felten PC, et al. Solitary nonepidermotropic T cell pseudolymphoma of the skin. J Am Acad Dermatol 1986;14:444-53.
24. Rijlaarsdam JU, Scheffer E, Meijer CJLM, et al. Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients. Cancer 1992;69:717-24.
25. Ackerman AB, Prez TS, Capland L. Spongiotic simulants of mycosis fungoides. Arch Dermatol 1974;109:218-20.
26. Fisher AA. Allergic contact dermatitis mimicking mycosis fungoides. Cutis 1987;40:19-21.
27. Orbaneja JG, Diez LI, Lozano JLS, et al. Lymphomatoid contact dermatitis: a syndrome produced by epicutaneous hypersensitivity with clinical features and a histopathologic picture similar to that of mycosis fungoides. Contact Dermatitis 1976;2:139-43.
28. Hawk JLM, Magnus IA. Chronic actinic dermatitis - an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol 1979;101(suppl 17):24.
29. Menage HP, Whittaker SJ, Ng YL, et al. Analysis of T-cell receptor genes in chronic actinic dermatitis: no evidence of clonality. [Abstract p 179]. Abstracts for the 1992 annual meeting of the European Society for Dermatological Research. London, England, April 4-7, 1992. J Invest Dermatol 1992;98:546.
30. Hara M, Matsunaga J, Tagami H. Acral pseudolymphomatous angiokeratoma of children (APACHE): a case report and immunohistologic study. Br J Dermatol 1991;124:387-8.
31. Fernandez-Figueres M-T, Puig L. Of APACHEs and PALEFACEs. Am J Dermatopathol 1995;17:209-11.
32. Bakels V, van Oostveen JW, van der Putte SC, et al. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between CTCLs and pseudo-T-cell lymphomas. Am J Pathol 1997;150:1941-9.
33. Moll M, Reinhold U, Kukel S, et al. CD7-negative helper T-cells accumulate in inflammatory skin lesions. J Invest Dermatol 1994; 102:328-32.
34. Heald P. CTCLs: the approach to the patient with CTCL. Presented at the American Academy of Dermatology Annual Meeting Symposium, February 27-March 4 1998, Orlando, FL.
35. Lambert WC, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol 1981;5:373-95.
36. Brocq L. Les parapsoriasis. Ann Dermatol Syphilol 1902;3: 433-68.
37. Unna PG, Santi S, Politer S. Ueber die Parakeratosen im allgemeinen und eine neue Form derselben (Parakeratosis variegata). Monatsschr Prakt Dermatol 1890;10:404-12, 444-59.
38. Goldberg LG. Xanthoerythrodermia perstans. Arch Dermatol 1963;88:901-907.
39. Yeager JK, Posnak EJ, Cobb MW. Digitate dermatosis. Cutis 1991;48:457-458.
40. Samman PD. The natural history of parapsoriasis en plaques (chronic superficial dermatitis) and prereticulotic poikiloderma. Br J Dermatol 1972;87:405-411.
41. Benmaman O, Sanchez JL. Comparative clinicopathologic study on pityriasis lichenoides chronica and small plaque parapsoriasis. Am J Dermatopathol 1988;10:189-196.
42. King ID, Ackerman AB. Guttate parapsoriasis/digitate dermatosis (small plaque parapsoriasis) is mycosis fungoides. Am J Dermatopathol 1992;14:518-30.
43. Ackerman AB. If small plaque (digitate) parapsoriasis is a CTCL, even an "abortive" one, it must be mycosis fungoides! Arch Dermatol 1996;132:562-566.
44. Burg G, Dummer R. Small plaque (digitate) parapsoriasis is an "abortive CTCL" and is not mycosis fungoides. Arch Dermatol 1995;131:336-338.
45. Burg G, Dummer R, Nestle FO, et al. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol 1996;132:567-572.
46. Haeffner AC, Smoller BR, Zepter K, et al. Differentiation and clonality of lesional lymphocytes in small plaque parapsoriasis. Arch Dermatol 1995;131:321-324.
47. Lazar AP, Caro WA, Roenigk HH Jr, et al. Parapsoriasis and mycosis fungoides: the Northwestern University experience, 1970-1985. J Am Acad Dermatol 1989;21:919-23.
48. Olerud JE, Kulin PA, Chew DE, et al. CTCL evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol 1992;128:501-507.
49. Barnhill RL, Braverman IM. Progression of pigmented purpuralike eruptions to mycosis fungoides. Report of 3 cases. J Am Acad Dermatol 1988;19:25-31.
50. Puddu P, Ferranti G, Frezzolini A, et al. Pigmented purpura-like eruption as a cutaneous sign of mycosis fungoides with autoimmune purpura. J Am Acad Dermatol 1999;40(2 part 2):298-9.
51. Farmer A, Jackow C, Manning JT, et al. Unusual presentation of mycosis fungoides as pigmented purpura with malignant thymoma. J Am Acad Dermatol 1998;39:858-63.
52. Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods. Am J Dermatopathol 1997;19:108-18.
53. Martinez W, del Pozo J, Vazquez J, et al. CTCL presenting as disseminated pigmented purpura-like eruption. Int J Dermatol 2001;40:140-4.
54. Jackow CM, Pharm D, Papadopoulos E, et al. Follicular mucinosis associated with scarring alopecia, oligoclonal T-cell receptor V-beta expansion, and Staphylococcus aureus: When does follicular mucinosis become mycosis fungoides? J Am Acad Dermatol 1997;37:828-831.
55. Hempstead RW, Ackerman AB. Follicular mucinosis. A reaction pattern in follicular epithelium. Am J Dermatopathol 1985;7: 245-7.
56. Emmerson RW. Follicular mucinosis. A study of 47 patients. Br J Dermatol 1969;81:395-413.
57. Nickoloff BJ, Wood C. Benign idiopathic versus mycosis-fungoides- associated follicular mucinosis. Pediatr Dermatol 1985;2:201-6.
58. Zackheim HS, Vonderheid EC, Ramsay DL, et al. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000;43(5 part 1);793-6.
59. Ketron LW, Goodman MH. Multiple lesions of the skin apparently of epithelial origin resembling clinically mycosis fungoides. Arch Dermatol 1931;24:758-777.
60. Burg G, Schmockel C. Syringolymphoid hyperplasia with alopecia - a syringotropic CTCL? Dermatology 1992;184:306-7.
61. Zelger B, Sepp N, Weyrer K, et al. Syringotropic CTCL: a variant of mycosis fungoides? Br J Dermatol 1994;130:765-9.
62. Kossard S, White A, Killingsworth M. Basaloid folliculolymphoid hyperplasia with alopecia as an expression of mycosis fungoides. J Cutan Pathol 1995;22:466-71.
63. Howard MS, Smoller BR. Mycosis fungoides: classic disease and variant presentations. Semin Cutan Med Surg 2000;19:91-9.
64. Hodak E, Feinmesser M, Segal T, et al. Follicular CTCL: a clinicopathologic study of nine cases. Br J Dermatol 1999;141: 315-22.
65. Klemke C-D, Dippel E, Assaf C, et al. Follicular mycosis fungoides. Br J Dermatol 1999;141:137-40.
66. Pestarino A, Borghi S, Dexxana M, et al. Asymptomatic follicular papules with alopecia on the lower part of the leg. Follicular mycosis fungoides. Arch Dermatol 2001;137:657-62.
67. Peters MS, Thibodeau SN, White JW, et al. Mycosis fungoides in children and adolescents. J Am Acad Dermatol 1990;22:1011-8.
68. Quaglino P, Zaccagna A, Verrone A, et al. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course. Dermatology 1999;199: 8-14.
69. Zackheim HS, Epstein EH, Jr, Grekin DA, et al. Mycosis fungoides presenting as areas of hypopigmentation: a report of three cases. J Am Acad Dermatol 1982;6:340-345.
70. Lambroza E, Cohen SR, Phelps R, et al. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol 1995;32:987-993.
71. Neuhaus IM, Ramos-Caro FA, Hassanein AM. Hypopigmented mycosis fungoides in childhood and adolescence. Pediatr Dermatol 2000;5:403-6.
72. Stone ML, Styles AR, Cockerell CJ, et al. Hypopigmented mycosis fungoides: a report of seven cases and review of the literature. Cutis 2000;67:133-8.
73. di Landro A, Marchesi L, Naldi L, et al. A case of hypopigmented mycosis fungoides in a young Caucasian boy. Pediatr Dermatol 1997;14:449-52.
74. Breathnach SM, McKee PH, Smith NP. Hypopigmented mycosis fungoides: report of five cases with ultrastructural observations. Br J Dermatol 1982;106:643-9.
75. Goldberg DJ, Schinella RA, Kechijian P. Hypopigmented mycosis fungoides: speculations about the mechanism of hypopigmentation. Am J Dermatopathol 1986;8:326-30.
76. Sigal M, Grossin M, Laroche L, et al. Hypopigmented mycosis fungoides. Clin Exp Dermatol 1987;12:453-4.
77. LeBoit PE, Zackheim HS, White CR, Jr. Granulomatous variants of CTCL. The histopathology of granulomatous mycosis fungoides and granulomatous slack skin. Am J Surg Pathol 1988;12: 83-95.
78. Fischer M, Wohlrab J, Audring T, et al. Granulomatous mycosis fungoides. Report of two cases and review of the literature. J Eur Acad Dermatol Venereol 2000;14:196-202.
79. Willemze R, Berljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993;28:973-80.
80. Tomaszewski M-M, Lupton GP, Krishnan J, et al. A comparison of clinical, morphologic and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30 (Ki-1)-positive anaplastic large-cell lymphoma. J Cutan Pathol 1995; 22:310-8.
81. Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299:65-7.
82. Beljaards RC, Meijer CJ, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989; 135:1169-78.
83. Pallesen G. The diagnostic significance of the CD30 (Ki-1) antigen. Histopathology 1990;16:409-413.
84. LeBoit PE. Lymphomatoid papulosis and cutaneous CD30+ lymphoma. Am J Dermatopathol 1996;18:221-235.
85. Macaulay WL. Lymphomatoid papulosis. A continuing selfhealing eruption, clinically benign - histologically malignant. Arch Dermatol 1968;97:23-30.
86. Willemze R. Lymphomatoid papulosis. Dermatol Clin 1985;3: 735-57.
87. Paulli M, Berti E, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin: clinicopathologic correlation and statistical analysis of 86 cases. A multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995;13: 1343-1354.
88. Karp DL, Horn TD. Lymphomatoid papulosis. J Am Acad Dermatol 1994;30:379-395.
89. Scarisbrick JJ, Calonje E, Orchard G, et al. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients. J Am Acad Dermatol 2001;44:239-47.
90. Wood GS, Strickler JG, Deneau DG, et al. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation. J Am Acad Dermatol 1986;15: 444-458.
91. Weiss LM, Wood GS, Trela M, et al. Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986;315:475-9.
92. Wood GS, Crooks CF, Uluer AZ. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin. J Invest Dermatol 1995;105:51-55.
93. Kadin ME. Anaplastic large cell lymphoma and its morphologic variants. Cancer Surv 1997;30:77-86.
94. Chan JKC, Buchanan R, Fletcher CDM. Sarcomatoid variant of anaplastic large cell lymphoma. Am J Surg Pathol 1990;14: 983-8.
95. Mann KP, Hall B, Kamino H, et al. Neutrophil-rich, Ki-1 positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol 1995;19:407-16.
96. Camisa C, Helm TN, Sexton C, et al. Ki-1 positive anaplastic large cell lymphoma can mimic benign dermatoses. J Am Acad Dermatol 1993;29:696-700.
97. Simonart T, Kentos A, Renoirte C, et al. Cutaneous involvement by neutrophil-rich, CD30-positive anaplastic large cell lymphoma mimicking deep pustules. Am J Surg Pathol 1999;23:244-6.
98. Grange F, Avril MF, Duvillard P, et al. Lymphome à grandes cellules anaplastiques Kil+ en tissu sous-cutané avec aspect clinique de panniculite. Ann Dermatol Venereol 1992;119:890-2.
99. Montemarano A, Rowe JE, Benson PM, et al. Ki-1 (CD30)- positive anaplastic large cell lymphoma mimicking an infectious granuloma. Int J Dermatol 1995;34:790-3.
100. Takimoto Y, Tanaka H, Tanabe O, et al. Anaplastic large cell lymphoma (Ki-1 lymphoma) with expression of IL-5 mRNA and eosinophilic invasion. Acta Hematol 1996;96:245-8.
101. McCluggage WG, Walsh MY, Bharucha H. Anaplastic large cell malignant lymphoma with extensive eosinophilic or neutrophilic infiltration. Histopathology 1998;32:110-5.
102. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 1990;16:383-91.
103. Chott AA, Kaserer K, Augustin I, et al. Ki-1-positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol 1990;14:439-48.
104. Kinney MC, Collins RD, Greer JP, et al. Small cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 1993;17:859-868.
105. Kummer JA, Vermeer MH, Dukers D, et al. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4- positive cytotoxic T-cell phenotype. J Invest Dermatol 1997;109: 636-40.
106. Kinney MC, Kadin ME. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol 1999;111(1 suppl 1):S56-67.
107. Beylot-Barry M, Lamant L, Vergier B, et al. Detection of t(2;5) (p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996;149:483-492.
108. DeCoteau JF, Butmarc JR, Kinney MC, et al. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996;87:3437-41.
109. Li G, Salhany KE, Rook AH, et al. The pathogenesis of large cell transformation in CTCL is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol 1997;24:403-8.
110. Diamandidou E, Colome M, Fayad L, et al. Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 1999;40(6 part 1):914-24.
111. Topar G, Zelger B, Schmuth M, et al. Granulomatous slack skin: a distinct disorder or a variant of mycosis fungoides. Acta Dermatol Venereol 2001;81:42-4.
112. Mouly F, Baccard M, Cayuela JM, et al. CTCL associated with granulomatous slack skin. Dermatology 1996;192:288-90.
113. Balus L, Manente L, Remotti D, et al. Granulomatous slack skin: report of a case and review of the literature. Am J Dermatopathol 1996;18:199-206.
114. Degregorio R, Fenske NE, Glass LF. Granulomatous slack skin: a possible precursor of Hodgkin's disease. J Am Acad Dermatol 1995;33:1044-1047.
115. Van Hasalen CW, Toonstra J, van der Putte SJC, et al. Granulomatous slack skin. Report of three cases with an updated review of the literature. Dermatology 1998;196:382-91.
116. Camacho FM, Burg G, Moreno JC. Granulomatous slack skin in childhood. Pediatr Dermatol 1997;14:204-8.
117. Tsang WY, Chan JK, Loo KT, et al. Granulomatous slack skin. Histopathology 1994;25:49-55.
118. LeBoit PE, Beckstead JH, Bond B, et al. Granulomatous slack skin: clonal rearrangement of the T-cell receptor beta gene is evidence for the lymphoproliferative nature of a cutaneous elastolytic disorder. J Invest Dermatol 1987;89:183-6.
119. Grammatico P, Balus L, Scarpa S, et al. Granulomatous slack skin: cytogenetics and molecular analyses. Cancer Genet Cytogenet 1994;72:96-100.
120. Noto G, Pravata G, Miceli S, et al. Granulomatous slack skin: report of a case associated with Hodgkin's disease and a review of the literature. Br J Dermatol 1994;131:275-9.
121. Guerra A, Borrego L, Romero G, et al. Granulomatous slack skin syndrome and histiocytosis X [Abstract P82A]. Presented at the 18th World Congress of Dermatology, New York, NY June 15-16, 1992.
122. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitic-like T-cell lymphoma: an elusive case presenting as lipomembranous panniculitis plus a review of 72 cases in the literature. Am J Dermatopathol 2001;23:206-15.
123. Von den Driesch P, Staib G, Simon M, Jr, et al. Subcutaneous panniculitic T-cell lymphoma. J Am Acad Dermatol 1997;36(2 part 2):285-9.
124. Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991:15:17-27.
125. Perniciaro C, Zalla MJ, White JW, Jr, et al. Subcutaneous panniculitic T-cell lymphoma. Arch Dermatol 1993;129:1171-6.
126. Mehregan DA, Su WPD, Kurtin PJ. Subcutaneous panniculitic T-cell lymphoma: a clinical, histopathologic, and immunohistochemical study of six cases. J Cutan Pathol 1994;21:110-7.
127. Jang K-A, Choi J-H, Sung K-J, et al. Primary CD56+ nasal-type T/natural killer-cell subcutaneous panniculitic lymphoma: presentation as haemophagocytic syndrome. Br J Dermatol 1999; 141:706-9.
128. Chang S-E, Huh J, Choi J-H, et al. Clinicopathologic features of CD56+ nasal-type T/natural killer cell lymphomas with lobular panniculitis. Br J Dermatol 2000;142:924-30.
129. Yamashita Y, Tsuzuki T, Nakayama A, et al. A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis-like T cell lymphoma. Pathol Int 1999;49:241-6.
130. Kumar S, Krenacs L, Medeiros J, et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol 1998;29:397-403.
131. Dargent J-L, Roufosse C, Delville J-P, et al. Subcutaneous pan-niculitis- like T-cell lymphoma: further evidence for a distinct neoplasm originating from large granular lymphocytes of T/NK phenotype. J Cutan Pathol 1998;25:394-400.
132. Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001;19:2179-88.
133. Bastian BC, Ott G. Primary cutaneous natural killer/T-cell lymphoma. Arch Dermatol 1998;134:109-11.
134. Munn SE, McGregor JM, Jones A, et al. Clinical and pathologic heterogeneity in cutaneous gamma-delta T-cell lymphoma: a report of three cases and a review of the literature. Br J Dermatol 1996;135:976-81.
135. Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitic T-cell lymphoma. Am J Surg Pathol 1998;7:881-93.
136. Kluin PM, Feller A, Gaulard P, et al. Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association of Haematopathology. Histopathology 2001;38:250-70.
137. Harada H, Iwatsuki K, Kaneko F. Detection of Epstein-Barr virus genes in malignant lymphoma with clinical and histologic features of cytophagic histiocytic panniculitis. J Am Acad Dermatol 1994;31:379-83.
138. Winkelmann RK, Bowie EJ. Hemorrhagic diathesis associated with benign histiocytic, cytophagic panniculitis and systemic histiocytosis. Arch Intern Med 1980;140:1460-3.
139. Wick MR, Patterson JW. Cytophagic histiocytic panniculitis - a critical reappraisal. Arch Dermatol 2000;136:922-4.
140. Huilgol SC, Fenton D, Pambakian H, et al. Fatal cytophagic panniculitis and hemophagocytosis syndrome. Clin Exp Dermatol 1998;23:51-5.
141. Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992;9:63-74.
142. Smith KJ, Skelton HG, Yeager J, et al. Cutaneous, histopathologic, immunohistochemical, and clinical manifestations in patients with hemophagocytic syndrome. Arch Dermatol 1992;128: 193-200.
143. Craig AJ, Cualing H, Thomas G, et al. Cytophagic histiocytic panniculitis; a syndrome associated with benign and malignant panniculitis: case comparison and review of the literature. J Am Acad Dermatol 1998;39(5 part 1): 721-36.
144. Baselga E, Pujol RM, Costa I, et al. Subcutaneous angiocentric T-cell lymphoma associated with fatal hemophagocytic syndrome. Int J Dermatol 1997;36:363-7.
145. Simrell CR, Margolick JB, Crabtree GR, et al. Lymphokine induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. Blood 1985;65: 1459-76.
146. Marzano AV, Berti E, Paulli M, et al. Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma. Arch Dermatol 2000;136:889-96.
147. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic γδ T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998:91:1723-31.
148. Kadin ME. Cutaneous gamma/delta T-cell lymphomas - how and why should they be recognized? Arch Dermatol 2000;136: 1052-4.
149. Toro JR, Beaty M, Sorbara L, et al. Gamma/delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol 2000;136:1024-32.
150. Avinoach I, Halevy S, Argov S, et al. Gamma/delta T-cell lymphoma involving the subcutaneous tissue and associated with a hemophagocytic syndrome. Am J Dermatopathol 1994;16: 426-33.
151. Fujita M, Miyachi Y, Furukawa F, et al. A case of CTCL expressing gamma delta T-cell receptors. J Am Acad Dermatol 1993;28:355-60.
152. Burg G, Dummer R, Wilhelm M, et al. A subcutaneous deltapositive T-cell lymphoma that produces interferon gamma. N Engl J Med 1991;325:1078-81.
153. Berti E, Cerri A, Cavicchini S, et al. Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 1991;96:718-23.
154. Alaibac M, Chu A. Pagetoid reticulosis: a γδ T-cell lymphoma? Eur J Dermatol 1992;2:109-11.
155. Abe Y, Muta K, Ohshima K, et al. Subcutaneous panniculitis by Epstein-Barr virus-infected natural killer (NK) cell proliferation terminating in aggressive subcutaneous NK cell lymphoma. Am J Hematol 2000;64:221-5.
156. Felgar RE, Macon WR, Kinney MC, et al. TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 1997;150:1893-900.
157. Chan JKC, Yip TTC, Ma VWS, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-46.
158. Natkunam Y, Smoller BR, Warnke RA, et al. Aggressive cutaneous NK and NK-like T-cell lymphomas. Am J Surg Pathol 1999;23:571-81.
159. Mason WR, Williams WE, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996;87:1474-83.
160. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1994;83:1207-10.
161. Chan JK, Sin VC, Lau WH, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89: 4501-13.
162. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1005;19:284-96.
163. Tsai TF, Chen RL, Su IJ, et al. Epstein-Barr virus-associated lymphoproliferative disorder of granular lymphocytes presenting initially as cutaneous vasculitis. J Am Acad Dermatol 1994;30: 339-44.
164. Savoia P, Fierro MT, Bernengo MG, et al. CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997;137:966-71.
165. Ansai S, Maeda K, Iwatsuki K, et al. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin: report of two cases and review of the literature. J Cutan Pathol 1997;24:468-76.
166. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11.
167. Takeshita M, Akamatsu M, Ohshima K, et al. Angiocentric immunoproliferative lesions of the skin show lobular panniculitis and are mainly disorders of large granular lymphocytes. Hum Pathol 1995;26:1321-8.
168. Guinee DJ, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis: evidence for a proliferation of Epstein-Barr infected B-lymphocytes with a prominent T cell component and vasculitis. Am J Surg Pathol 1994;18:753-64.
169. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv 1997;30: 233-48.
170. Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 1990;22:569-77.
171. Urrutia S, Piris MA, Orradre JL, et al. Cytotoxic/suppressor (CD8+/CD4-) CTCL with aggressive course. Am J Dermatopathol 1990;12:603-6.
172. Fujiwara Y, Abe Y, Kuyama M, et al. CD8+ CTCL with pagetoid epidermotropism and angiocentric and angiodestructive infiltration. Arch Dermatol 1990;126:801-804.
173. Kikuchi A, Naka W, Harada T, et al. Primary CD8+ lymphoepithelioid lymphoma of the skin. J Am Acad Dermatol 1993;29: 419-22.
174. Quarterman MJ, Lesher JL, Jr, Davis LS, et al. Rapidly progressive CD8-positive CTCL with tongue involvement. Am J Dermatopathol 1995;17:287-91.
175. Berti E, Tomasin D, Vermeer MH, et al. Primary cutaneous CD8- positive epidermotropic cytotoxic T-cell lymphomas: a distinct clinicopathologic entity with aggressive clinical behavior. Am J Pathol 1999;155:483-91.
176. Salieh MN, LeMaistre CF. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides. J Am Acad Dermatol 1998; 39:63-73.
177. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T cell receptor gene rearrangements in early mycosis fungoides/Sézary syndrome by PCR and denaturing gradient gel electrophoresis. J Invest Dermatol 1994;103:34-41.
178. Kohler S, Jones CD, Warnke RA, et al. PCR-heteroduplex analysis of T-cell receptor gamma gene rearrangement in paraffinembedded skin biopsies. Am J Dermatopathol 2000;22:321-7.
179. Weinberg JM, Rook AH, Lessin SR. Molecular diagnosis of lymphocytic infiltrates of the skin. Arch Dermatol 1993;129:1491-500.
180. Whitaker S. T cell receptor gene analysis in cutaneous T cell lymphomas. Clin Exp Dermatol 1996;21:81-7.
181. Griesser H, Feller AC, Sterry W. T-cell receptor and immunoglobulin gene rearrangements in cutaneous T-cell-rich pseudolymphomas. J Invest Dermatol 1990; 95:292-5.
182. Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant. precursor, or both. Am J Dermatopathol 1997;19:108-18.
183. Weiss LM, Wood GS, Ellisen LW, et al. Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha Habermann disease). Am J Pathol 1987;126:417-21.
184. Bignon YT, Souteyrand P. Genotyping of cutaneous T-cell lymphomas and pseudolymphomas. Curr Probl Dermatol 1990;19:114-23.